vs
Side-by-side financial comparison of Edison International (EIX) and GE HealthCare (GEHC). Click either name above to swap in a different company.
Edison International is the larger business by last-quarter revenue ($5.2B vs $5.1B, roughly 1.0× GE HealthCare). Edison International runs the higher net margin — 35.4% vs 8.0%, a 27.4% gap on every dollar of revenue. On growth, Edison International posted the faster year-over-year revenue change (30.8% vs 7.4%). GE HealthCare produced more free cash flow last quarter ($112.0M vs $-319.0M). Over the past eight quarters, Edison International's revenue compounded faster (13.1% CAGR vs 3.0%).
Edison International is a public utility holding company based in Rosemead, California. Its subsidiaries include Southern California Edison, and unregulated non-utility business assets Edison Energy. Edison's roots trace back to Holt & Knupps, a company founded in 1886 as a provider of street lights in Visalia, California.
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
EIX vs GEHC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.2B | $5.1B |
| Net Profit | $1.8B | $411.0M |
| Gross Margin | — | 38.5% |
| Operating Margin | 52.8% | 10.0% |
| Net Margin | 35.4% | 8.0% |
| Revenue YoY | 30.8% | 7.4% |
| Net Profit YoY | 443.5% | -31.0% |
| EPS (diluted) | $4.78 | $0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $5.1B | ||
| Q4 25 | $5.2B | $5.7B | ||
| Q3 25 | $5.8B | $5.1B | ||
| Q2 25 | $4.5B | $5.0B | ||
| Q1 25 | $3.8B | $4.8B | ||
| Q4 24 | $4.0B | $5.3B | ||
| Q3 24 | $5.2B | $4.9B | ||
| Q2 24 | $4.3B | $4.8B |
| Q1 26 | — | $411.0M | ||
| Q4 25 | $1.8B | $588.0M | ||
| Q3 25 | $832.0M | $446.0M | ||
| Q2 25 | $343.0M | $486.0M | ||
| Q1 25 | $1.4B | $564.0M | ||
| Q4 24 | $340.0M | $721.0M | ||
| Q3 24 | $516.0M | $470.0M | ||
| Q2 24 | $439.0M | $428.0M |
| Q1 26 | — | 38.5% | ||
| Q4 25 | — | 39.7% | ||
| Q3 25 | — | 38.7% | ||
| Q2 25 | — | 39.6% | ||
| Q1 25 | — | 42.1% | ||
| Q4 24 | — | 42.8% | ||
| Q3 24 | — | 41.7% | ||
| Q2 24 | — | 41.4% |
| Q1 26 | — | 10.0% | ||
| Q4 25 | 52.8% | 14.5% | ||
| Q3 25 | 24.9% | 12.7% | ||
| Q2 25 | 17.1% | 13.1% | ||
| Q1 25 | 56.0% | 13.2% | ||
| Q4 24 | 19.8% | 15.1% | ||
| Q3 24 | 19.1% | 13.9% | ||
| Q2 24 | 20.8% | 12.6% |
| Q1 26 | — | 8.0% | ||
| Q4 25 | 35.4% | 10.3% | ||
| Q3 25 | 14.5% | 8.7% | ||
| Q2 25 | 7.6% | 9.7% | ||
| Q1 25 | 37.7% | 11.8% | ||
| Q4 24 | 8.5% | 13.6% | ||
| Q3 24 | 9.9% | 9.7% | ||
| Q2 24 | 10.1% | 8.8% |
| Q1 26 | — | $0.85 | ||
| Q4 25 | $4.78 | $1.28 | ||
| Q3 25 | $2.16 | $0.98 | ||
| Q2 25 | $0.89 | $1.06 | ||
| Q1 25 | $3.72 | $1.23 | ||
| Q4 24 | $0.89 | $1.58 | ||
| Q3 24 | $1.32 | $1.02 | ||
| Q2 24 | $1.13 | $0.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.0M | — |
| Total DebtLower is stronger | $38.0B | $10.1B |
| Stockholders' EquityBook value | $17.6B | $10.7B |
| Total Assets | $94.0B | $37.1B |
| Debt / EquityLower = less leverage | 2.16× | 0.95× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $158.0M | $4.5B | ||
| Q3 25 | $364.0M | $4.0B | ||
| Q2 25 | $140.0M | $3.7B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | $193.0M | $2.9B | ||
| Q3 24 | $200.0M | $3.5B | ||
| Q2 24 | $465.0M | $2.0B |
| Q1 26 | — | $10.1B | ||
| Q4 25 | $38.0B | $10.0B | ||
| Q3 25 | $36.4B | $10.3B | ||
| Q2 25 | $37.7B | $10.3B | ||
| Q1 25 | $38.4B | $8.8B | ||
| Q4 24 | $35.6B | $9.0B | ||
| Q3 24 | $34.9B | $10.3B | ||
| Q2 24 | $34.8B | $9.2B |
| Q1 26 | — | $10.7B | ||
| Q4 25 | $17.6B | $10.4B | ||
| Q3 25 | $17.2B | $10.0B | ||
| Q2 25 | $16.7B | $9.7B | ||
| Q1 25 | $16.6B | $9.2B | ||
| Q4 24 | $15.6B | $8.4B | ||
| Q3 24 | $15.7B | $8.3B | ||
| Q2 24 | $15.4B | $7.8B |
| Q1 26 | — | $37.1B | ||
| Q4 25 | $94.0B | $36.9B | ||
| Q3 25 | $90.5B | $36.1B | ||
| Q2 25 | $88.8B | $35.5B | ||
| Q1 25 | $88.4B | $33.6B | ||
| Q4 24 | $85.6B | $33.1B | ||
| Q3 24 | $84.7B | $33.9B | ||
| Q2 24 | $84.8B | $31.9B |
| Q1 26 | — | 0.95× | ||
| Q4 25 | 2.16× | 0.96× | ||
| Q3 25 | 2.12× | 1.03× | ||
| Q2 25 | 2.26× | 1.06× | ||
| Q1 25 | 2.31× | 0.95× | ||
| Q4 24 | 2.29× | 1.06× | ||
| Q3 24 | 2.23× | 1.24× | ||
| Q2 24 | 2.26× | 1.18× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.6B | — |
| Free Cash FlowOCF − Capex | $-319.0M | $112.0M |
| FCF MarginFCF / Revenue | -6.1% | 2.2% |
| Capex IntensityCapex / Revenue | 36.3% | — |
| Cash ConversionOCF / Net Profit | 0.85× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-715.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $882.0M | $94.0M | ||
| Q1 25 | $1.2B | $250.0M | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $2.5B | — | ||
| Q2 24 | $329.0M | $-119.0M |
| Q1 26 | — | $112.0M | ||
| Q4 25 | $-319.0M | — | ||
| Q3 25 | $618.0M | — | ||
| Q2 25 | $-830.0M | $8.0M | ||
| Q1 25 | $-184.0M | $98.0M | ||
| Q4 24 | $-326.0M | — | ||
| Q3 24 | $961.0M | — | ||
| Q2 24 | $-1.1B | $-183.0M |
| Q1 26 | — | 2.2% | ||
| Q4 25 | -6.1% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | -18.3% | 0.2% | ||
| Q1 25 | -4.8% | 2.1% | ||
| Q4 24 | -8.2% | — | ||
| Q3 24 | 18.5% | — | ||
| Q2 24 | -25.2% | -3.8% |
| Q1 26 | — | — | ||
| Q4 25 | 36.3% | 2.4% | ||
| Q3 25 | 26.2% | 2.1% | ||
| Q2 25 | 37.7% | 1.7% | ||
| Q1 25 | 36.9% | 3.2% | ||
| Q4 24 | 37.6% | 1.9% | ||
| Q3 24 | 29.1% | 1.9% | ||
| Q2 24 | 32.8% | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.85× | — | ||
| Q3 25 | 2.55× | — | ||
| Q2 25 | 2.57× | 0.19× | ||
| Q1 25 | 0.85× | 0.44× | ||
| Q4 24 | 3.44× | — | ||
| Q3 24 | 4.79× | — | ||
| Q2 24 | 0.75× | -0.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EIX
| Commercial | $2.2B | 43% |
| Residential | $1.2B | 23% |
| Other | $966.0M | 19% |
| Other Operating Revenue | $802.0M | 15% |
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
